TREACE MED CONCEPTS INC shareholders Q3 2023

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

TREACE MED CONCEPTS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BlackRock Inc. 3,457,302$45,325,2300.00%
D. E. Shaw & Co., Inc. 68,249$894,7440.00%
TWO SIGMA ADVISERS, LP 19,100$250,4010.00%
JPMORGAN CHASE & CO 348,568$4,569,7270.00%
PEAK6 Investments LLC 22,100$289,7310.00%
SIMPLEX TRADING, LLC 791$100.00%
CITIGROUP INC 111$1,4560.00%
US BANCORP \DE\ 85$1,1140.00%
WELLS FARGO & COMPANY/MN 10,546$138,2590.00%
VAN ECK ASSOCIATES CORP 4,093$540.00%
PRINCIPAL FINANCIAL GROUP INC 13,348$174,9920.00%
GOLDMAN SACHS GROUP INC 122,051$1,600,0880.00%
MORGAN STANLEY 213,506$2,799,0640.00%
Covestor Ltd 5$00.00%
COMERICA BANK 569$7,4600.00%
UBS Group AG 125$1,6390.00%
PEAK6 Investments LLC 2,100$27,5310.00%
CWM, LLC 3,225$420.00%
WOLVERINE TRADING, LLC 11,900$156,0090.00%
Russell Investments Group, Ltd. 17$2230.00%
External links

This page lists TREACE MED CONCEPTS INC's shareholders in Q3 2023. To view TREACE MED CONCEPTS INC's shareholder history, click here.